MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 11-07-2024
Axonics Modulation Technologies Retained Earnings 2011-2026 | AXNX
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings Axonics Modulation Technologies
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -374 M | -315 M | -234 M | -180 M | -99.6 M | -67.2 M | -49.1 M | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -49.1 M | -374 M | -188 M |
Quarterly Retained Earnings Axonics Modulation Technologies
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -393 M | -393 M | -399 M | -380 M | - | -391 M | - | -374 M | -375 M | - | -337 M | -315 M | -299 M | -282 M | -257 M | -234 M | -234 M | -234 M | -234 M | -180 M | -180 M | -180 M | -180 M | -99.6 M | -99.6 M | -99.6 M | -99.6 M | -67.2 M | -67.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -67.2 M | -399 M | -246 M |
Retained Earnings of other stocks in the Medical devices industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BIOLASE
BIOL
|
-317 M | - | -13.19 % | $ 166 K |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-533 M | - | - | $ 1.77 B | USA |
 |
AdaptHealth Corp.
AHCO
|
-633 M | $ 13.25 | 1.26 % | $ 1.79 B | USA |
 |
Allied Healthcare Products
AHPI
|
-15.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
BioSig Technologies
BSGM
|
-718 M | - | 37.08 % | $ 85.7 M | USA |
 |
Avinger
AVGR
|
-421 M | - | -20.74 % | $ 369 K | USA |
 |
Aziyo Biologics
AZYO
|
-176 M | - | 1.37 % | $ 20.5 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-185 M | - | -5.86 % | $ 30.6 M | USA |
 |
Cardiovascular Systems
CSII
|
-424 M | - | 0.15 % | $ 844 M | USA |
 |
Electromed
ELMD
|
21.2 M | $ 25.74 | -1.0 % | $ 218 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-82.6 M | $ 3.27 | 1.55 % | $ 122 M |  France |
 |
Conformis
CFMS
|
-581 M | - | - | $ 16.4 M | USA |
 |
Dynatronics Corporation
DYNT
|
-40.5 M | - | 14.99 % | $ 929 K | USA |
 |
Globus Medical
GMED
|
1.39 B | $ 91.17 | -2.7 % | $ 12.3 B | USA |
 |
Cytosorbents Corporation
CTSO
|
-312 M | $ 0.61 | 0.36 % | $ 38 M | USA |
 |
Apollo Endosurgery
APEN
|
-337 M | - | - | $ 475 M | USA |
 |
ClearPoint Neuro
CLPT
|
-217 M | $ 11.02 | -1.69 % | $ 312 M | USA |
 |
Helius Medical Technologies
HSDT
|
-160 M | $ 2.11 | -0.71 % | $ 1.28 M | USA |
 |
Eargo
EAR
|
-514 M | - | - | $ 10.2 M | USA |
 |
CryoLife, Inc.
CRY
|
20 M | - | -4.14 % | $ 702 M | USA |
 |
Second Sight Medical Products
EYES
|
-149 M | - | -0.97 % | $ 54.4 M | USA |
 |
LENSAR
LNSR
|
-178 M | $ 5.39 | 3.45 % | $ 64.5 M | USA |
 |
GBS
GBS
|
-62.5 M | - | -0.57 % | $ 7.12 M | USA |
 |
Soliton, Inc.
SOLY
|
-70.6 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-56.2 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-119 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
LivaNova PLC
LIVN
|
-1.15 B | $ 60.72 | -4.24 % | $ 3.31 B |  Britain |
 |
Misonix, Inc.
MSON
|
-39.3 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-395 M | - | - | $ 111 M |  Canada |
 |
Orthofix Medical
OFIX
|
-368 M | $ 11.92 | -3.25 % | $ 472 M |  Curacao |
 |
PAVmed
PAVM
|
-259 M | $ 8.85 | 5.36 % | $ 5.93 M | USA |
 |
Pulmonx Corporation
LUNG
|
-522 M | $ 1.22 | -4.69 % | $ 49.6 M | USA |
 |
Butterfly Network
BFLY
|
-802 M | $ 5.22 | -4.84 % | $ 1.1 B | USA |
 |
Intersect ENT, Inc.
XENT
|
-303 M | - | - | $ 955 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-275 M | $ 15.25 | -3.6 % | $ 358 M | USA |
 |
Delcath Systems
DCTH
|
-529 M | $ 10.68 | -1.52 % | $ 383 M | USA |
 |
IRIDEX Corporation
IRIX
|
-92.4 M | $ 1.04 | -3.7 % | $ 17.6 M | USA |
 |
CONMED Corporation
CNMD
|
589 M | $ 36.48 | -3.67 % | $ 1.13 B | USA |
 |
Inspire Medical Systems
INSP
|
-146 M | $ 55.28 | 0.38 % | $ 1.62 B | USA |
 |
Sintx Technologies
SINT
|
-292 M | $ 2.24 | -4.85 % | $ 6.21 M | USA |
 |
Integer Holdings Corporation
ITGR
|
994 M | $ 84.37 | -1.15 % | $ 2.93 B | USA |
 |
Invacare Corporation
IVC
|
-78.4 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
14.2 B | $ 81.94 | -1.82 % | $ 47.9 B | USA |
 |
Stryker Corporation
SYK
|
20.5 B | $ 321.01 | -2.43 % | $ 123 B | USA |
 |
Tactile Systems Technology
TCMD
|
54.9 M | $ 23.0 | -5.12 % | $ 526 M | USA |
 |
TELA Bio
TELA
|
-398 M | $ 0.78 | -2.46 % | $ 36.6 M | USA |
 |
MiMedx Group
MDXG
|
-42.7 M | $ 3.39 | 1.35 % | $ 501 M | USA |